Liddicoat John R 4

4 · Medtronic plc · Filed Jun 1, 2021

Form 4

Period: 2021-05-28

EVP & President of Americas

Transactions

Exercise/Conversion
Ordinary Shares
2021-05-28$78.00/sh+17,095$1,333,410→ 59,646 total
Exercise/Conversion
Ordinary Shares
2021-05-28$78.00/sh+1,283$100,074→ 60,929 total
Exercise/Conversion
Ordinary Shares
2021-05-28$88.06/sh+1,136$100,036→ 62,065 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-05-28−1,283→ 0 total
Exercise: $78.00From: 2016-08-03Exp: 2025-08-03→ Ordinary Shares (1,283 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-05-28−1,136→ 0 total
Exercise: $88.06From: 2017-08-01Exp: 2026-08-01→ Ordinary Shares (1,136 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-05-28−15,142→ 0 total
Exercise: $88.06From: 2017-08-01Exp: 2026-08-01→ Ordinary Shares (15,142 underlying)
Exercise/Conversion
Ordinary Shares
2021-05-28$88.06/sh+15,142$1,333,405→ 77,207 total
Sale
Ordinary Shares
2021-05-28$126.65/sh−34,656$4,389,182→ 42,551 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-05-28−17,095→ 0 total
Exercise: $78.00From: 2016-08-03Exp: 2025-08-03→ Ordinary Shares (17,095 underlying)

Footnotes (3)

[F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
[F2]This balance increased by 562 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan.
[F3]These options become exercisable at the rate of 25% of the shares granted per year beginning one year from grant date.

Documents

1 file